Authors: | Murphy, B.; Muss, H. B. |
Article Title: | Hormonal therapy of breast cancer: State of the art |
Abstract: | Hormonal therapy has an established role in the treatment of women with metastatic breast cancer and also is now a major component of adjuvant systemic therapy for those with early-stage disease. Moreover, recent data suggest that hormonal agents may have a potential use in the prevention of breast cancer in high-risk groups. This article will provide a general overview of the current roles of hormonal therapy and describe future directions that show particular promise. |
Keywords: | prednisone; review; chemotherapy, adjuvant; metastasis; breast cancer; transforming growth factor beta; estrogen; estrogens; breast neoplasms; risk factor; goserelin; leuprorelin; drug mechanism; tamoxifen; forecasting; diethylstilbestrol; hormonal therapy; aminoglutethimide; antiandrogen; antineoplastic agents, hormonal; anastrozole; growth factor; transforming growth factor alpha; fulvestrant; megestrol acetate; medroxyprogesterone acetate; toremifene; raloxifene; fluoxymesterone; estrogen antagonists; humans; human; female; buserelin; n butyl 11 (3,17beta dihydroxyestra 1,3,5(10) trien 7alpha yl) n methylundecanamide; idoxifene; droloxifene; miproxifene phosphate; trioxifene; zindoxifene |
Journal Title: | Oncology (Norwalk) |
Volume: | 11 |
Issue: | 5 Suppl. 4 |
ISSN: | 0890-9091 |
Publisher: | C M P Medica LLC * The Oncology Group |
Date Published: | 1997-05-01 |
Start Page: | 7 |
End Page: | 13 |
Language: | English |
PUBMED: | 9165500 |
PROVIDER: | scopus |
DOI/URL: | |
Notes: | Review -- Export Date: 17 March 2017 -- Source: Scopus |